Zicam and Orajel
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
Zicam Products
Case Name (Date)
Yamasaki et al v. Zicam LLC and Matrixx Initiatives, Inc.
21-cv-2596, N.D. Cal.
(June 2021)
Product/Service
Zicam Original RapidMelts, Zicam ULTRA RapidMelts, Zicam Elderberry Citrus RapidMelts, Zicam Nasal Swabs, Zicam Nasal Spray, Zicam Wild Cherry Lozenges, and Zicam Oral Mist
Allegations
Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
Status
Dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.
Class-Action Tracker
Zicam Pre-Cold Remedies
Zicam Pre-Cold Medicine Products
The Latest
The Ordinary: The Periodic Fable
From empty promises to impossible standards and overhyped ingredients: for too long, the beauty industry has taught beauty wrong.
Skull Shaver’s Early Bird Sale
Trying to take advantage of this sale may not be as smooth as advertised.
Roblox Bid for Ad Riches Collides With Wary Sponsors, Developers
Cecilia D’Anastasio, Bloomberg
UIC Aspire Grant
TINA.org digs into school’s debt-free claims.
TINA.org Joins Consumer Advocates to Keep FTC Bipartisan
Why agency independence is in the best interests of consumers.